Pender Growth Fund (PTF) Stock Price, News & Analysis

Company Overview

Pender Growth Fund Inc. specializes in later stage, special situations, and restructuring investments. The fund also provides expansion capital and invests in small caps and Eligible Small Businesses ("ESBs"). It seeks to invest in illiquid public and private companies in information technology, communications, life sciences, and proprietary technologies sectors and undervalued technology companies. The fund targets companies based in British Columbia, Canada. It typically invests over Cdn $500,000 ($0.51) or invests between Cdn $1.5 million ($1.53 million) and Cdn $3 million ($3.06 million) in each portfolio company with revenues between Cdn $5 million ($5.10 million) and Cdn $15 million ($15.30 million). The fund prefers to invest in undervalued public companies.

Key Stats

• Today's Range: C$14.40 to C$14.89
• 50-Day Range: C$10.15 to C$14.89
• 52-Week Range: C$9.29 to C$14.99
• Volume: 2,800 shs
• Average Volume: 3,006 shs
• Market Capitalization: C$107.96 million
• P/E Ratio: 2.40
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PTF Stock Analysis - Frequently Asked Questions

How have PTF shares performed this year?

Pender Growth Fund's stock was trading at C$11.19 at the beginning of 2025. Since then, PTF shares have increased by 33.1% and is now trading at C$14.89.

How do I buy shares of Pender Growth Fund?

Shares of PTF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Pender Growth Fund own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pender Growth Fund investors own include Armata Pharmaceuticals (ARMP), BioCardia (BCDA), Bristol Myers Squibb (BMY), Range Cancer Therapeutics ETF (CNCR), Inovio Pharmaceuticals (INO), Insight Select Income Fund (INSI) and Protalix BioTherapeutics (PLX).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: CVE:PTF
• CIK: N/A
• Web: www.pendergrowthfund.com
• Phone: 604-688-1511
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C$6.20
• Trailing P/E Ratio: 2.40
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$44.92 million
• Net Margins: 90.98%
• Pretax Margin: N/A
• Return on Equity: 49.26%
• Return on Assets: 25.87%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: 51.12

Sales & Book Value

• Annual Sales: C$49.38 million
• Price / Sales: 2.19
• Cash Flow: C$1.78 per share
• Price / Cash Flow: 8.35
• Book Value: C$15.08 per share
• Price / Book: 0.99

Miscellaneous

• Outstanding Shares: 7,250,430
• Free Float: N/A
• Market Cap: C$107.96 million
• Optionable: Not Optionable
• Beta: 0.56